Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aliphos was a leading European manufacturer of high-quality inorganic feed phosphates for the animal nutrition sector. Originally the feed phosphate division of Tessenderlo Group, it was acquired by EcoPhos in 2013 and became a central part of their global operations. The company specialized in the production of dicalcium phosphate, monocalcium phosphate, and magnesium phosphates used to enhance livestock health and productivity. Its products were essential for bone development and metabolic functions in poultry, pigs, and cattle. Following the bankruptcy of the EcoPhos Group in 2020, the Aliphos brand and its commercial assets were acquired by EuroChem. The business continues to operate as part of EuroChem's broader phosphate portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aliphos Belgium.